Dextromethorphan metabolic phenotyping in an Iranian population

被引：0
|
作者：
Minoo Afshar
Mohammadreza Rouini
Shahram Ala
机构：
[1] Tehran University of Medical Sciences,Biopharmaceutics and Pharmacokinetics Division, Department of Pharmaceutics, Faculty of Pharmacy
[2] Mazandaran University of Medical Sciences,Department of Clinical Pharmacy, Faculty of Pharmacy
来源：
European Journal of Clinical Pharmacology | 2005年 / 60卷
关键词：
Dextromethorphan; Iranian Population; Metabolic Ratio; Arylsulfatase; Dextrorphan;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：849 / 854
页数：5
相关论文
共 50 条
  • [21] ASSESSMENT OF THE DEBRISOQUIN AND DEXTROMETHORPHAN PHENOTYPING TESTS BY GAUSSIAN MIXTURE DISTRIBUTIONS ANALYSIS
    HENTHORN, TK
    BENITEZ, J
    AVRAM, MJ
    MARTINEZ, C
    LLERENA, A
    COBALEDA, J
    KREJCIE, TC
    GIBBONS, RD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (03) : 328 - 333
  • [22] Comparison of various urine collection intervals for caffeine and dextromethorphan phenotyping in children
    Kennedy, MJ
    Abdel-Rahman, SM
    Kashuba, ADM
    Leeder, JS
    JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (07): : 708 - 714
  • [23] Dextromethorphan As a Phenotyping Test to Predict Endoxifen Exposure in Patients on Tamoxifen Treatment
    de Graan, Anne-Joy M.
    Teunissen, Sebastiaan F.
    de Vos, Filip Y. F. L.
    Loos, Walter J.
    van Schaik, Ron H. N.
    de Jongh, Felix E.
    de Vos, Aad I.
    van Alphen, Robbert J.
    van der Holt, Bronno
    Verweij, Jaap
    Seynaeve, Caroline
    Beijnen, Jos H.
    Mathijssen, Ron H. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (24) : 3240 - 3246
  • [24] Metabolic syndrome and health-related quality of life in Iranian population
    Sarrafzadegan, Nizal
    Gharipour, Mojgan
    Ramezani, Mohammad Arash
    Rabiei, Katayoun
    Zolfaghar, Behzad
    Tavassoli, Ali Akbar
    Boshtam, Maryam
    Zarfeshani, Sonia
    Khosravi, Alireza
    Yousefi, Alireza
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2011, 16 (03): : 254 - 261
  • [25] Dextromethorphan to dextrorphan urinary metabolic ratio does not reflect dextromethorphan oral clearance
    Borges, S
    Li, L
    Hamman, MA
    Jones, DR
    Hall, SD
    Gorski, JC
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (07) : 1052 - 1055
  • [26] GC AND GC-MS PROCEDURES FOR SIMULTANEOUS PHENOTYPING WITH DEXTROMETHORPHAN AND MEPHENYTOIN
    BAUMANN, P
    JONZIERPEREY, M
    CLINICA CHIMICA ACTA, 1988, 171 (2-3) : 211 - 222
  • [27] The metabolic syndrome and incident diabetes: Assessment of alternative definitions of the metabolic syndrome in an Iranian urban population
    Hadaegh, Farzad
    Ghasemi, Asghar
    Padyab, Mojgan
    Tohidi, Mayyam
    Azizi, Fereidoun
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 80 (02) : 328 - 334
  • [28] The metabolic syndrome and incident diabetes: assessment of alternative definitions of the metabolic syndrome in an Iranian urban population
    Ghasemi, Asghar
    Hadaegh, Farzad
    Padyab, Mojgan
    Tohidi, Maryam
    Azizi, Fereidoun
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 : S95 - S95
  • [29] Cutoff point of waist circumference for the diagnosis of metabolic syndrome in an Iranian population
    Sharifi, F.
    Mousavinasab, N.
    Mazloomadeh, S.
    Jaberi, Y.
    Saeini, M.
    Dinmohammadi, M.
    Angomshoaa, A.
    OBESITY RESEARCH & CLINICAL PRACTICE, 2008, 2 (03) : 171 - 178
  • [30] DEXTROMETHORPHAN (DX) POPULATION-KINETICS
    MILLER, RP
    GRAVES, DA
    MUIR, KT
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (02) : 149 - 149
12345